Cellana, Inc. is an algae biotechnology company that grows microalgae outdoors using sunlight. According to its own platform page, it has combined with PhytoSmart, a consumer brand for whole-algae pet supplements, through an acquisition. The combined business describes an algae nutrition platform covering omega-3 fatty acids, plant-based proteins and ingredients for food, feed, supplements and specialty uses.
Outdoor algae production
The company states that it has run industrial-scale outdoor photosynthetic production for more than a decade in Hawaii, Florida, Arizona, Georgia and California. Its patented ALDUO hybrid system is credited with about 30,000 kilograms of algae biomass, which the company says validated unit economics and scalability. Those are company figures, and a buyer should request the underlying production records.
Outdoor growth contrasts with enclosed fermentation. Sunlight and carbon dioxide replace sugar, so the process avoids a sugar feedstock, but yields depend on climate and contamination control. The company points to feed trials and to data from the US Department of Energy supported Algae Testbed Public-Private Partnership, in which its data was named the 2016 State of Technology benchmark.
The platform page describes high-yield, EPA-rich microalgae. The genus Nannochloropsis is widely used for EPA-rich biomass, and background on it is on the page for nannochloropsis protein, but a buyer should ask the company which species and strain are grown, because composition, colour and regulatory status follow from the species and the cultivation conditions.
PhytoSmart and the product pathway
PhytoSmart contributes a consumer brand with repeat purchasers and seven active products as of 2025, which the company expects to double in 2026. Its patented Sterile Plastic Algal Growth System supports indoor whole-cell algae fermentation at low capital cost. Current products are whole-algae DHA omega-3 supplements for pets, sold through an online marketplace, the PhytoSmart site and growing retail channels.
The stated plan moves from pet nutrition into human nutrition, functional foods and ingredient markets beginning in 2026. Four directions are listed: whole-algae omega-3s, plant-based proteins, EPA and DHA complexes for nutraceutical and pharmaceutical uses, and clean, non-GMO fish-free omega-3 solutions. Protein ingredients are therefore a planned line, and no specification is published for them on the platform page.
For a protein buyer, the practical consequence is that Cellana is an early-stage partner for algae protein, not a catalogue supplier. The company describes plant-based proteins as sustainable protein ingredients for food and feed applications. A developer should ask whether a protein concentrate exists, at what protein level and how the oil is separated.
Evaluation notes for buyers
Whole algae biomass has fixed limits in food. It is strongly coloured, usually green or brown, and carries marine or grassy notes. Cell walls of some species resist digestion unless they are disrupted by milling or heat. A protein concentrate needs cell disruption and separation, which raises cost, so the price per kilogram of protein depends on the process route.
Regulatory status is species and market specific. In the United States, an algae ingredient needs GRAS status or an approved food additive pathway, and in the European Union many microalgae need novel food authorisation unless a consumption history exists. The platform page makes no claim of approval, so a buyer should ask for the status in each target market.
Ask for a specification sheet covering protein, lipid, fatty acid profile, moisture, ash, chlorophyll, heavy metals, microbiological limits and any pesticide or biocide residue from open ponds. Outdoor systems face contamination, so the company should explain how it manages grazers, competing algae and bacteria, and whether batch records and traceability are available to customers.
Supply planning matters as well. The company says its pathway is staged, with near-term revenue from consumer products and longer-term scale from the industrial platform. A buyer should ask where the biomass is currently produced, how much is available for ingredients and which investments are needed to reach larger volumes, then agree on a pilot quantity with defined acceptance tests.
The website offers wholesale, distributor and investor inquiry routes, which indicates that several commercial models are open. A food manufacturer should use the wholesale or ingredient contact route, describe the application, target protein level and annual volume, and ask for a development plan that names the milestones, the sample size and the data to be delivered at each step.